|
MechanismPeptide hydrolase inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismFSHR negative allosteric modulator |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Inflamalps SA
0 Patents (Medical) associated with Inflamalps SA
100 Deals associated with Inflamalps SA
100 Translational Medicine associated with Inflamalps SA